Fig. 2From: Recent advances of CREKA peptide-based nanoplatforms in biomedical applicationsT1-weighted MR imaging of lung metastases in vivo. A MR images and H&E stained images after 20Â min of injection of UMFNP-CREKA. B MRI-based proportion of lung metastases area. C Quantified bioluminescence imaging intensity. D Proportion of lung metastases area based on H&E staining [58]Back to article page